ReviewIndian journal of pediatrics2026
Artificial Intelligence in Clinical Genetics: Current Applications and Challenges.
Review in Indian journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiomics, next-generation, and long-read sequencing approaches have transformed the practice of medical genetics. Complex cases often require several person-hours to make sense of the tens of thousands to millions of variants and biochemical patterns in each patient. Availability of massive datasets challenges traditional analytical and interpretive approaches. Artificial intelligence offers powerful ways to handle the growing volume and complexity of genomic and phenotypic data in clinical genetics. It is already influencing several areas of practice, including variant prioritization and interpretation, rare disease screening, and aspects of precision medicine. However, translating these advances into routine clinical use has proven difficult due to the underrepresentation of various populations, ethical issues, and issues related to data governance. As the majority of these tools are used in isolation, separate from hospital information systems and routine reporting pipelines, they are not optimally utilized. With continued progress in precision medicine and genomics, these AI genomic tools are likely to be integrated more into medical genetics practice, rather than remaining restricted to specialised or experimental settings.
Indexed as
Identifiers
42443618What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.